ADAM12-cleaved ephrin-A1 contributes to lung metastasis

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Eph receptor tyrosine kinases and ephrin ligands are crucial in development and neovascularization.
• Ephrin-A1 overexpression correlates with tumor progression and poor prognosis, but underlying mechanisms remain unclear.

Purpose of the Study:

• To elucidate the role of the Eph/ephrin system in cell adhesion and its contribution to tumor metastasis.
• To identify molecular mechanisms linking EphA1/ephrin-A1 signaling to tumor progression and vascular permeability.

Main Methods:

• Investigated EphA1/ephrin-A1 complex behavior (endocytosis, cell adhesion) in pulmonary endothelial cells.
• Utilized yeast two-hybrid screening to identify EphA1-binding partners.
• Assessed the impact of ADAM12 and transforming growth factor-β1 on ephrin-A1 cleavage.
• Evaluated the effect of soluble ephrin-A1 and neutralizing antibodies on lung metastasis and vascular permeability in vivo.

Main Results:

• Clustered EphA1/ephrin-A1 complexes resist endocytosis, maintaining cell-cell adhesion independently of Eph tyrosine kinase activity and E-cadherin.
• EphA1 and ephrin-A1 co-localize in pulmonary endothelial cells, regulating vascular permeability and lung metastasis.
• ADAM12 was identified as an EphA1-binding partner that enhances ephrin-A1 cleavage in response to TGF-β1.
• Soluble ephrin-A1 promotes lung hyperpermeability and metastasis in an endocrine manner, which is significantly inhibited by its neutralizing antibody.

Conclusions:

• The Eph/ephrin system mediates cell adhesion through non-degradative plasma membrane complexes.
• ADAM12-mediated cleavage of ephrin-A1 contributes to lung metastasis by increasing vascular permeability.
• Targeting soluble ephrin-A1 presents a potential therapeutic strategy to inhibit tumor metastasis.